InvestorsHub Logo
Followers 77
Posts 3440
Boards Moderated 0
Alias Born 02/11/2004

Re: wickerman post# 46

Monday, 12/27/2010 5:12:05 PM

Monday, December 27, 2010 5:12:05 PM

Post# of 79
It's just a matter of time. One by one the sub-$1 biotechs are getting nice runs. None of those have earnings, many are listing deficient. Technically KUN still is but they at least have an accepted compliance plan from Amex. Regardless, this one is thin, profitable, and I am happy to own it from the low .50's

Solid DD combined with timeliness and conviction is a recipe for profits.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.